Skip to content

In the BioHarmony Drug Report Database

Vonicog alfa

Vonvendi, Veyvondi (vonicog alfa) is a protein pharmaceutical. Vonicog alfa was first approved as Vonvendi on 2018-08-31. It has been approved in Europe to treat von willebrand diseases.
Trade Name Veyvondi
Common Name Vonicog alfa
Indication von willebrand diseases
Drug Class Hemostatic
Vonicog alfa
Get full access now